|
|
|
Volumn 26, Issue 1 SUPPL. 4, 1999, Pages 31-36
|
|
Overview of MTA in the treatment of non-small cell lung cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
DEXAMETHASONE;
DOCETAXEL;
FOLIC ACID ANTAGONIST;
GEMCITABINE;
IRINOTECAN;
NAVELBINE;
PACLITAXEL;
PEMETREXED;
TAXANE DERIVATIVE;
ADULT;
AGED;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
DRUG EFFICACY;
FEMALE;
GRANULOCYTOPENIA;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MALE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
SKIN TOXICITY;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
CLINICAL TRIALS;
ENZYME INHIBITORS;
GLUTAMATES;
GUANINE;
HUMANS;
LUNG NEOPLASMS;
|
|
EID: 0032893109
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (13)
|
|
References (35)
|
